Blau Syndrome-Associated Uveitis and the NOD2 Gene

References

• Martin TM, Doyle TM, Smith Jr. Dinulesu D, et al. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003;136:933–935
   PubMedGoogle Scholar
• Kurko J, Besenyei T, Laki J, et al. Genetics of rheumatoid arthritis: A comprehensive review. Clin Rev Allergy Immunol. 2013;5
   Google Scholar
• Fischer A, Nothagel M, Schürmann M, et al. A genome-wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers. Chest 2010;138(1):151–157
   PubMedGoogle Scholar
• Blau EB. Familial granulomatous arthritis, iritis and rash. J Pediat. 1985;107:689–693
   PubMed Web of Science ®Google Scholar
• Jabs DA, Houk JL, Bias WB, Arnett FC. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 1985;78:801–804
   PubMed Web of Science ®Google Scholar
• Miller JJ III. Early-onset sarcoidosis and “familial granulomatous arthritis (arteritis)”: The same disease. J Pediatr 1986;109(2):109387–109388
   Google Scholar
• Saini SK and Rose CD. Liver involvement in familial granulomatous arthritis (Blau syndrome). J Rheum 1996;23:396–399
   PubMed Web of Science ®Google Scholar
• Ting SS, Ziegler J, Fischer E. Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr 1998;133:450–452
   PubMedGoogle Scholar
• Emaminia A, Nabavi M, Mousavi NM, Kashef S. Central nervous system involvement in Blau syndrome: A new feature of the syndrome? J Rheumatol 2007;34(12):2504–2505
   PubMedGoogle Scholar
• Masel G, Halbert A. Blau syndrome presenting with ichthyosis. Australas J Dermatol 2005;46:29–32
   PubMedGoogle Scholar
• Wang X, Kuivaniemi H, Bonavita G, et al. CARD15 mutations in familial granulomatosis syndromes. Arthritis Rheum 2002;46(11):3041–3045
   PubMed Web of Science ®Google Scholar
• Mourad F, Tang A. Sinus of vaslava aneurysm in Blau’s syndrome. J Cardiothorac Surd 2010;5:16
   PubMedGoogle Scholar
• Raju P, Hasija R, Touitou I, et al. Blau arteritis resembling Takayasu Disease with a novel NOD2 Mutation. J Rheumatol 2012;39:1888–1892
   PubMedGoogle Scholar
• Rose CD, Aróstegui JI, Martin TM, et al. NOD2-Associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in Spain. Arthritis Rheum 2009;60:1797–1803
   PubMed Web of Science ®Google Scholar
• Latkany PA, Jabs DA, Smith JR, et al. Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am J Ophthalmol 2002;134:897–904
   PubMedGoogle Scholar
• Gass DA 2nd, Maender J, Metry D, et al. Two pediatric cases of Blau syndrome. Dermatology Online Journal 2009;15:5
   Google Scholar
• Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatosis inflammatory arthritis, skin rash and uveitis to chromosome 16. Am J Hum Genet 1996;59:1097–1107
   PubMed Web of Science ®Google Scholar
• Okafuji I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum 2009;60:242–250
   PubMed Web of Science ®Google Scholar
• Pattishell EN, Strope GL, Spinola SM, Denny FW. Childhood sarcoidosis. Pediatrics 1986;108:169–177
   Google Scholar
• Kanazawa N, Matsushima S, Kambe N, et al. Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J Invest Derm 2004;122:851–852
   PubMed Web of Science ®Google Scholar
• Rose CD, Doyle TM, McIlvain-Simpson G, et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005;32:373–375
   PubMed Web of Science ®Google Scholar
• Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nature Genet 2001;29:19–20
   PubMed Web of Science ®Google Scholar
• Raiji VR, Miller MM, Jung LK. Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene. J AAPOS 2011;15:205–207
   PubMed Web of Science ®Google Scholar
• Saulsbury FT, Wouters CH, Martin TM, et al. Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum 2009;60:1804–1806
   PubMedGoogle Scholar
• Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: Common genetic etiology with Blau syndrome. Blood 2005;10(3):1195–1197
   Google Scholar
• Snyers B, Dahan K. Blau syndrome associated with a CARD15/NOD2 mutation. Am J Ophthalmol 2006;142(6):1421089–1421092
   Google Scholar
• Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 2001;276(7):4812–4818
   PubMed Web of Science ®Google Scholar
• Eckmann L, Karin M. NOD2 and Crohn's disease: Loss or gain of function? Immunity 2005;22(6):661–667
   PubMedGoogle Scholar
• Sfriso P, Caso F, Tognon S, et al. Blau syndrome, clinical and genetic aspects. Autoimmunity Reviews 2012;12:44–51
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Martin TM, Jann MM, et al. NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis. Invest Ophthalmol Vis Sci 2008;49:1518–1524
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Kawaguchi T, Martin TM, et al. Nucleotide oligomerization domain-2(NOD2) induced uveitis: Dependence on IFN gamma. IOVS 2009 Apr:1739–1745
   PubMedGoogle Scholar
• Rosenbaum JT, Planck SR, Davey MP, et al. With a mere nod, uveitis enters a new era. Am J Ophthalmol 2003;136:729–732
   PubMed Web of Science ®Google Scholar
• Davey MP, Martin TM, Planck SR, et al. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvascular Res 2006;71:103–107
   PubMedGoogle Scholar
• Rosenzweig HL, Martin TM, Planck SR, et al. Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling. J Leukoc Biol 2008 Aug;84(2):529–536
   PubMedGoogle Scholar
• Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010;11:55–62
   PubMed Web of Science ®Google Scholar
• Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010;16:90–97
   PubMed Web of Science ®Google Scholar
• Zhu K, Yin X, Tang X, et al. Meta-analysis of NOD2/CARD15 polymorphisms with psoriasis and psoriatic arthritis. Rheumatol Int 2012;32(7):1893–1900
   PubMed Web of Science ®Google Scholar
• Nguyen Y, Al-Lehibi A, Gorbe E, et al. Insufficient evidence for the association of NOD2/CARD15 or other inflammatory bowel disease associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation. Blood 2010;115(17):3625–3631
   PubMedGoogle Scholar
• Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Chrohn’s disease. Nature 2001;411:603–606
   PubMed Web of Science ®Google Scholar
• Inohara H, Chamaillard M, McDonald C, Nuñez G. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005;74:355–383
   PubMed Web of Science ®Google Scholar
• Milman N, Andersen CB, Hansen A, et al. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 2006;14:912–919
   Google Scholar
• Rose CD, Martin TM, Wouters CH. Blau syndrome revisited. Curr Opin Rheumatol 2011;23:411–418
   PubMed Web of Science ®Google Scholar
• Yasui K, Yashiro M, Tsuge M, et al. Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: Its possible action and mechanism. Arthritis Rheum 2010;63:250–257
   Google Scholar
• Cunningham ET Jr. Uveitis in children. Ocul Immunol Inflamm 2000;8:251–261
   PubMed Web of Science ®Google Scholar
• Aróstegui JI, Arnal C, Merino R, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 2007 Nov;56(11):3805–3813
   PubMed Web of Science ®Google Scholar
• Martin TM, Zhang Z, Kurz P, et al. The NOD2 defect in Blau Syndrome does not result in excess interleukin-1 activity. Arthritis Rheum 2009;60(2):611–618
   PubMedGoogle Scholar
• Simonini G, Xu Z, Caputo R, et al. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 2013;65(2):513–518
   PubMed Web of Science ®Google Scholar